Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel
Moldiag Erkrankungen Gene Support Kontakt

Fibroblasten-Wachstumsfaktor-Rezeptor 3

Das FGFR3-Gen kodiert ein FGF-Rezeptor. Mutationen diese Gens führen zu verschiedenen Dysmorphie Syndromen wie zum Beispiel Achondroplasie und Crouzon-Syndrom.

Gentests:

Forschung Untersuchungsmethoden Familienuntersuchung
Bearbeitungszeit 5 Tage
Probentyp genomische DNS
Klinisch Untersuchungsmethoden Hochdurchsatz-Sequenzierung
Bearbeitungszeit 25 Tage
Probentyp genomische DNS
Klinisch Untersuchungsmethoden Direkte Sequenzierung der proteinkodierenden Bereiche eines Gens
Bearbeitungszeit 25 Tage
Probentyp genomische DNS

Verknüpfte Erkrankungen:

Thanatophore Dysplasie 2
FGFR3
Thanatophore Dysplasie 1
FGFR3
Achondroplasie
FGFR3
Crouzon-Syndrom
FGFR3
Muenke-Syndrom
FGFR3

Referenzen:

1.

McKusick VA et al. (1973) Observations suggesting allelism of the achondroplasia and hypochondroplasia genes.

external link
2.

Superti-Furga A et al. (1995) A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondroplasia.

external link
3.

Bellus GA et al. (1995) Achondroplasia is defined by recurrent G380R mutations of FGFR3.

external link
4.

Shiang R et al. (1994) Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia.

external link
5.

Rousseau F et al. (1994) Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia.

external link
6.

Huggins MJ et al. (1999) Achondroplasia-hypochondroplasia complex in a newborn infant.

external link
7.

Chitayat D et al. (1999) Compound heterozygosity for the Achondroplasia-hypochondroplasia FGFR3 mutations: prenatal diagnosis and postnatal outcome.

external link
8.

Henderson S et al. (2000) Germline and somatic mosaicism in achondroplasia.

external link
9.

Sobetzko D et al. (2000) Achondroplasia with the FGFR3 1138g-->a (G380R) mutation in two sibs sharing a 4p haplotype derived from their unaffected father.

external link
10.

Yasoda A et al. (2004) Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway.

external link
11.

Van Esch H et al. (2004) Acanthosis nigricans in a boy with achondroplasia due to the classical Gly380Arg mutation in FGFR3.

external link
12.

Rump P et al. (2006) Severe complications in a child with achondroplasia and two FGFR3 mutations on the same allele.

external link
13.

Heuertz S et al. (2006) Novel FGFR3 mutations creating cysteine residues in the extracellular domain of the receptor cause achondroplasia or severe forms of hypochondroplasia.

external link
14.

Natacci F et al. (2008) Germline mosaicism in achondroplasia detected in sperm DNA of the father of three affected sibs.

external link
15.

Matsushita T et al. (2009) FGFR3 promotes synchondrosis closure and fusion of ossification centers through the MAPK pathway.

external link
16.

Moloney DM et al. (1996) Exclusive paternal origin of new mutations in Apert syndrome.

external link
17.

Meyers GA et al. (1995) Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans.

external link
18.

Arnaud-López L et al. (2007) Crouzon with acanthosis nigricans. Further delineation of the syndrome.

external link
19.

Singh D et al. (2012) Transforming fusions of FGFR and TACC genes in human glioblastoma.

external link
20.

Rohmann E et al. (2006) Mutations in different components of FGF signaling in LADD syndrome.

external link
21.

Muenke M et al. (1997) A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome.

external link
22.

Reardon W et al. (1997) Craniosynostosis associated with FGFR3 pro250arg mutation results in a range of clinical presentations including unisutural sporadic craniosynostosis.

external link
23.

Golla A et al. (1997) Phenotypic expression of the fibroblast growth factor receptor 3 (FGFR3) mutation P250R in a large craniosynostosis family.

external link
24.

None (1997) Craniosynostosis: genes and mechanisms.

external link
25.

Hollway GE et al. (1998) Deafness due to Pro250Arg mutation of FGFR3.

external link
26.

Gripp KW et al. (1998) Identification of a genetic cause for isolated unilateral coronal synostosis: a unique mutation in the fibroblast growth factor receptor 3.

external link
27.

Lajeunie E et al. (1999) Sex related expressivity of the phenotype in coronal craniosynostosis caused by the recurrent P250R FGFR3 mutation.

external link
28.

Lowry RB et al. (2001) Syndrome of coronal craniosynostosis, Klippel-Feil anomaly, and sprengel shoulder with and without Pro250Arg mutation in the FGFR3 gene.

external link
29.

Rannan-Eliya SV et al. (2004) Paternal origin of FGFR3 mutations in Muenke-type craniosynostosis.

external link
30.

Mansour SL et al. (2009) Hearing loss in a mouse model of Muenke syndrome.

external link
31.

Chen L et al. (2001) A Ser(365)-->Cys mutation of fibroblast growth factor receptor 3 in mouse downregulates Ihh/PTHrP signals and causes severe achondroplasia.

external link
32.

Tavormina PL et al. (1995) Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3.

external link
33.

Tavormina PL et al. (1995) Another mutation that results in the substitution of an unpaired cysteine residue in the extracellular domain of FGFR3 in thanatophoric dysplasia type I.

external link
34.

Rousseau F et al. (1996) Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1).

external link
35.

Wilcox WR et al. (1998) Molecular, radiologic, and histopathologic correlations in thanatophoric dysplasia.

external link
36.

Sawai H et al. (1999) Prenatal diagnosis of thanatophoric dysplasia by mutational analysis of the fibroblast growth factor receptor 3 gene and a proposed correction of previously published PCR results.

external link
37.

Brodie SG et al. (1999) Platyspondylic lethal skeletal dysplasia, San Diego type, is caused by FGFR3 mutations.

external link
38.

Pannier S et al. (2009) Thanatophoric dysplasia caused by double missense FGFR3 mutations.

external link
39.

Lin T et al. (2003) A central nervous system specific mouse model for thanatophoric dysplasia type II.

external link
40.

Li D et al. (2006) Thanatophoric dysplasia type 2 with encephalocele during the second trimester.

external link
41.

Thompson LM et al. (1991) A gene encoding a fibroblast growth factor receptor isolated from the Huntington disease gene region of human chromosome 4.

external link
42.

Keegan K et al. (1991) Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3.

external link
43.

None (1988) Bone dysplasia 'families'.

external link
44.

Scotet E et al. (1995) The choice between alternative IIIb and IIIc exons of the FGFR-3 gene is not strictly tissue-specific.

external link
45.

Rousseau F et al. (1995) Stop codon FGFR3 mutations in thanatophoric dwarfism type 1.

external link
46.

Ikegawa S et al. (1995) Mutations of the fibroblast growth factor receptor-3 gene in one familial and six sporadic cases of achondroplasia in Japanese patients.

external link
47.

Bellus GA et al. (1995) A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia.

external link
48.

Avraham KB et al. (1994) Mapping of murine fibroblast growth factor receptors refines regions of homology between mouse and human chromosomes.

external link
49.

Prinos P et al. (1995) A common FGFR3 gene mutation in hypochondroplasia.

external link
50.

Nishimura G et al. (1995) Atypical radiological findings in achondroplasia with uncommon mutation of the fibroblast growth factor receptor-3 (FGFR-3) gene (Gly to Cys transition at codon 375)

external link
51.

Deng C et al. (1996) Fibroblast growth factor receptor 3 is a negative regulator of bone growth.

external link
52.

Colvin JS et al. (1996) Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3.

external link
53.

Naski MC et al. (1996) Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia.

external link
54.

von Gernet S et al. (1996) Craniosynostosis suggestive of Saethre-Chotzen syndrome: clinical description of a large kindred and exclusion of candidate regions on 7p.

external link
55.

Bellus GA et al. (1996) Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes.

external link
56.

Pokharel RK et al. (1996) Japanese cases of type 1 thanatophoric dysplasia exclusively carry a C to T transition at nucleotide 742 of the fibroblast growth factor receptor 3 gene.

external link
57.

Bergsagel PL et al. (1996) Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma.

external link
58.

Su WC et al. (1997) Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism.

external link
59.

Moloney DM et al. (1997) Prevalence of Pro250Arg mutation of fibroblast growth factor receptor 3 in coronal craniosynostosis.

external link
60.

Perez-Castro AV et al. (1997) Genomic organization of the human fibroblast growth factor receptor 3 (FGFR3) gene and comparative sequence analysis with the mouse Fgfr3 gene.

external link
61.

Chesi M et al. (1997) Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3.

external link
62.

Lanning RW et al. (1997) An improved methodology for the detection of the common mutation in the FGFR3 gene responsible for achondroplasia.

external link
63.

Prinster C et al. (1998) Comparison of clinical-radiological and molecular findings in hypochondroplasia.

external link
64.

Deutz-Terlouw PP et al. (1998) Asn540Thr substitution in the fibroblast growth factor receptor 3 tyrosine kinase domain causing hypochondroplasia.

external link
65.

Paznekas WA et al. (1998) Genetic heterogeneity of Saethre-Chotzen syndrome, due to TWIST and FGFR mutations.

external link
66.

Graham JM et al. (1998) Syndrome of coronal craniosynostosis with brachydactyly and carpal/tarsal coalition due to Pro250Arg mutation in FGFR3 gene.

external link
67.

Ramaswami U et al. (1998) Genotype and phenotype in hypochondroplasia.

external link
68.

Naski MC et al. (1998) Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3.

external link
69.

Angle B et al. (1998) Molecularly proven hypochondroplasia with cloverleaf skull deformity: a novel association.

external link
70.

Brodie SG et al. (1998) Thanatophoric dysplasia type I with syndactyly.

external link
71.

Robin NH et al. (1998) Nonpenetrance in FGFR3-associated coronal synostosis syndrome.

external link
72.

Li C et al. (1999) A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors.

external link
73.

Tavormina PL et al. (1999) A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene.

external link
74.

El Ghouzzi V et al. (1999) Mutations within or upstream of the basic helix-loop-helix domain of the TWIST gene are specific to Saethre-Chotzen syndrome.

external link
75.

Grigelioniené G et al. (1998) A novel missense mutation Ile538Val in the fibroblast growth factor receptor 3 in hypochondroplasia. Mutations in brief no. 122. Online.

external link
76.

Tsai FJ et al. (1999) Identification of a common N540K mutation in 8/18 Taiwanese hypochondroplasia patients: further evidence for genetic heterogeneity.

external link
77.

Fofanova OV et al. (1998) A missense mutation of C1659 in the fibroblast growth factor receptor 3 gene in Russian patients with hypochondroplasia.

external link
78.

Passos-Bueno MR et al. (1999) Clinical spectrum of fibroblast growth factor receptor mutations.

external link
79.

Cappellen D et al. (1999) Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas.

external link
80.

Tsai FJ et al. (1999) Mutations in the fibroblast growth factor receptor 3 (FGFR3) cause achondroplasia, hypochondroplasia, and thanatophoric dysplasia: Taiwanese data.

external link
81.

Chen L et al. (1999) Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis.

external link
82.

Monsonego-Ornan E et al. (2000) The transmembrane mutation G380R in fibroblast growth factor receptor 3 uncouples ligand-mediated receptor activation from down-regulation.

external link
83.

Henderson JE et al. (2000) Expression of FGFR3 with the G380R achondroplasia mutation inhibits proliferation and maturation of CFK2 chondrocytic cells.

external link
84.

Kitoh H et al. (1998) Lys650Met substitution in the tyrosine kinase domain of the fibroblast growth factor receptor gene causes thanatophoric dysplasia Type I. Mutations in brief no. 199. Online.

external link
85.

Mortier G et al. (2000) Clinical and radiographic features of a family with hypochondroplasia owing to a novel Asn540Ser mutation in the fibroblast growth factor receptor 3 gene.

external link
86.

Iwata T et al. (2000) A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos.

external link
87.

Saito H et al. (2000) Prenatal DNA diagnosis of a single-gene disorder from maternal plasma.

external link
88.

Bellus GA et al. (2000) Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype.

external link
89.

Shimizu A et al. (2001) A novel alternatively spliced fibroblast growth factor receptor 3 isoform lacking the acid box domain is expressed during chondrogenic differentiation of ATDC5 cells.

external link
90.

Sibley K et al. (2001) Loss of heterozygosity at 4p16.3 and mutation of FGFR3 in transitional cell carcinoma.

external link
91.

Jang JH et al. (2001) Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers.

external link
92.

Iwata T et al. (2001) Highly activated Fgfr3 with the K644M mutation causes prolonged survival in severe dwarf mice.

external link
93.

Roscioli T et al. (2001) Premature calvarial synostosis and epidermal hyperplasia (Beare-Stevenson syndrome-like anomalies) resulting from a P250R missense mutation in the gene encoding fibroblast growth factor receptor 3.

external link
94.

Karoui M et al. (2001) No evidence of somatic FGFR3 mutation in various types of carcinoma.

external link
95.

Intini D et al. (2001) Analysis of FGFR3 gene mutations in multiple myeloma patients with t(4;14).

external link
96.

Kimura T et al. (2001) The incidence of thanatophoric dysplasia mutations in FGFR3 gene is higher in low-grade or superficial bladder carcinomas.

external link
97.

Shimizu A et al. (2002) FGFR3 isoforms have distinct functions in the regulation of growth and cell morphology.

external link
98.

None (2002) Identification and characterization of soluble isoform of fibroblast growth factor receptor 3 in human SaOS-2 osteosarcoma cells.

external link
99.

Rasmussen T et al. (2002) FGFR3 dysregulation in multiple myeloma: frequency and prognostic relevance.

external link
100.

Lievens PM et al. (2003) The thanatophoric dysplasia type II mutation hampers complete maturation of fibroblast growth factor receptor 3 (FGFR3), which activates signal transducer and activator of transcription 1 (STAT1) from the endoplasmic reticulum.

external link
101.

Thauvin-Robinet C et al. (2003) Hypochondroplasia and stature within normal limits: another family with an Asn540Ser mutation in the fibroblast growth factor receptor 3 gene.

external link
102.

Hyland VJ et al. (2003) Somatic and germline mosaicism for a R248C missense mutation in FGFR3, resulting in a skeletal dysplasia distinct from thanatophoric dysplasia.

external link
103.

Ibrahimi OA et al. (2004) Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity.

external link
104.

Valverde-Franco G et al. (2004) Defective bone mineralization and osteopenia in young adult FGFR3-/- mice.

external link
105.

Cho JY et al. (2004) Defective lysosomal targeting of activated fibroblast growth factor receptor 3 in achondroplasia.

external link
106.

Su YN et al. (2004) Rapid detection of FGFR3 gene mutation in achondroplasia by DHPLC system-coupling heteroduplex and fluorescence-enhanced primer-extension analysis.

external link
107.

Logié A et al. (2005) Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans.

external link
108.

Davidson D et al. (2005) Fibroblast growth factor (FGF) 18 signals through FGF receptor 3 to promote chondrogenesis.

external link
109.

Nowroozi N et al. (2005) Sustained ERK1/2 but not STAT1 or 3 activation is required for thanatophoric dysplasia phenotypes in PC12 cells.

external link
110.

Wyrobek AJ et al. (2006) Advancing age has differential effects on DNA damage, chromatin integrity, gene mutations, and aneuploidies in sperm.

external link
111.

Hafner C et al. (2006) Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi.

external link
112.

Toydemir RM et al. (2006) A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome.

external link
113.

Eswarakumar VP et al. (2007) Skeletal overgrowth is mediated by deficiency in a specific isoform of fibroblast growth factor receptor 3.

external link
114.

Riley BM et al. (2007) Impaired FGF signaling contributes to cleft lip and palate.

external link
115.

Wilkie AO et al. (2007) Clinical dividends from the molecular genetic diagnosis of craniosynostosis.

external link
116.

Friez MJ et al. (2008) Novel FGFR3 mutations in exon 7 and implications for expanded screening of achondroplasia and hypochondroplasia: a response to Heuertz et al.

external link
117.

Leroy JG et al. (2007) Acanthosis nigricans in a child with mild osteochondrodysplasia and K650Q mutation in the FGFR3 gene.

external link
118.

Zankl A et al. (2008) Prenatal and postnatal presentation of severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN) due to the FGFR3 Lys650Met mutation.

external link
119.

García-Vargas A et al. (2008) An epidermal nevus syndrome with cerebral involvement caused by a mosaic FGFR3 mutation.

external link
120.

Almeida MR et al. (2009) Clinical and molecular diagnosis of the skeletal dysplasias associated with mutations in the gene encoding Fibroblast Growth Factor Receptor 3 (FGFR3) in Portugal.

external link
121.

Salazar L et al. (2009) A novel interaction between fibroblast growth factor receptor 3 and the p85 subunit of phosphoinositide 3-kinase: activation-dependent regulation of ERK by p85 in multiple myeloma cells.

external link
122.

Goriely A et al. (2009) Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors.

external link
123.

Su N et al. (2010) Gain-of-function mutation in FGFR3 in mice leads to decreased bone mass by affecting both osteoblastogenesis and osteoclastogenesis.

external link
124.

He L et al. (2010) Physical basis behind achondroplasia, the most common form of human dwarfism.

external link
125.

He L et al. (2011) FGFR3 heterodimerization in achondroplasia, the most common form of human dwarfism.

external link
126.

Barroso E et al. (2011) Mild isolated craniosynostosis due to a novel FGFR3 mutation, p.Ala334Thr.

external link
127.

Jacky BP et al. (2013) Identification of fibroblast growth factor receptor 3 (FGFR3) as a protein receptor for botulinum neurotoxin serotype A (BoNT/A).

external link
128.

Wang H et al. (2013) A novel missense mutation of FGFR3 in a Chinese female and her fetus with Hypochondroplasia by next-generation sequencing.

external link
129.

Makrythanasis P et al. (2014) A novel homozygous mutation in FGFR3 causes tall stature, severe lateral tibial deviation, scoliosis, hearing impairment, camptodactyly, and arachnodactyly.

external link
130.

Yamashita A et al. (2014) Statin treatment rescues FGFR3 skeletal dysplasia phenotypes.

external link
131.

NCBI article

NCBI 2261 external link
132.

OMIM.ORG article

Omim 134934 external link
133.

Orphanet article

Orphanet ID 121815 external link
Update: 14. August 2020
Copyright © 2005-2020 Zentrum für Nephrologie und Stoffwechsel, Dr. Mato Nagel
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Deutschland, Tel.: +49-3576-287922, Fax: +49-3576-287944
Seitenüberblick | Webmail | Haftungsausschluss | Datenschutz